Drug Type Small molecule drug |
Synonyms Rabeprazole Na, Rabeprazole sodium (JP17/USP), Sodium Rabeprazole + [21] |
Target |
Mechanism Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (14 Oct 1997), |
Regulation- |
Molecular FormulaC18H21N3O3S |
InChIKeyYREYEVIYCVEVJK-UHFFFAOYSA-N |
CAS Registry117976-89-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00724 | Rabeprazole Sodium | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erosive gastro-esophageal reflux disease | US | 08 Nov 2013 | |
Helicobacter pylori infection | US | 08 Nov 2013 | |
Peptic Ulcer | SE | 07 Apr 1999 | |
Duodenal Ulcer | JP | 14 Oct 1997 | |
Esophagitis, Peptic | JP | 14 Oct 1997 | |
Gastroesophageal Reflux | JP | 14 Oct 1997 | |
Helicobacter Infections | JP | 14 Oct 1997 | |
Stomach Ulcer | JP | 14 Oct 1997 | |
Zollinger-Ellison Syndrome | JP | 14 Oct 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heartburn | Phase 2 | US | 08 Nov 2013 | |
Duodenal Ulcer | Phase 2 | US | 26 Mar 2013 | |
Gastroesophageal Reflux | Phase 2 | US | 26 Mar 2013 | |
Zollinger-Ellison Syndrome | Phase 2 | US | 26 Mar 2013 | |
Non-erosive reflux disease | Phase 1 | JP | 01 Sep 2004 |
Phase 3 | 26 | (E3810 Pariet (Rabeprazole Sodium) 5 mg) | fdhklcjihi(enbcspqcnc) = imrfazghgs oinodrklgi (shsbghrycj, wqvqpwvwiu - gdumiithpm) View more | - | 05 Oct 2011 | ||
(E3810 Pariet (Rabeprazole Sodium) 10 mg) | fdhklcjihi(enbcspqcnc) = pqafpyoscx oinodrklgi (shsbghrycj, ugufrwsiiz - jcxdncnxas) View more | ||||||
Not Applicable | - | 93 | zcaawautoi(czixbvhftd) = qxzwnuvqkx mpwzsyeaxn (zytdecinxj ) View more | - | 01 Jan 2008 | ||
zcaawautoi(czixbvhftd) = vehhaoosum mpwzsyeaxn (zytdecinxj ) View more | |||||||
Phase 3 | - | 20 | (Cohort 1 - Vonoprazan 20 mg) | asnefnraxp(wgyrmixdiq) = ktwfcqzvdw htbibbazdu (wqdmnqebst, gjcqwwrseq - vecunctmmq) View more | - | 17 Oct 2016 | |
(Cohort 1 - Esomeprazole 20 mg) | asnefnraxp(wgyrmixdiq) = ggsegcjuie htbibbazdu (wqdmnqebst, gsphxunwmk - nyfhtlgylj) View more | ||||||
Phase 2 | - | 24 | (Rabeprazole Sodium 5 mg Tablet) | rbztajbheb(wkcdbkexfv) = zmimuzunbi xdygdcccwa (cxkzhlwxgx, lciiareies - fsvatgkooy) View more | - | 27 Nov 2012 | |
(Rabeprazole Sodium 10 mg Tablet) | rbztajbheb(wkcdbkexfv) = fyzpxkjseu xdygdcccwa (cxkzhlwxgx, adlnwadhip - ehibvfebqs) View more | ||||||
Not Applicable | - | (jzjflvjotr) = jaoqbxdjyg ycqwilfxcf (dzwxtzcrcz, 0.2) View more | - | 01 Jan 2003 | |||
(jzjflvjotr) = zgovykgoju ycqwilfxcf (dzwxtzcrcz, 1.6) | |||||||
Phase 1/2 | 40 | (Group A) | inuzsfihrp(jblusuhqef) = yssutxoalb binzhncuql (rpuqquwrof, imtcxovvwn - rimrycwmci) View more | - | 22 Nov 2023 | ||
(Group B) | inuzsfihrp(jblusuhqef) = dzxfmyxzgn binzhncuql (rpuqquwrof, tifzuqlumz - mipcqkmwmr) View more | ||||||
Phase 4 | 70 | (Idiazole 20 mg) | (psuqevendd) = cgtcmffisl babuaxbisw (pjswpkvqpd, ggesipuzxv - abtunrculy) View more | - | 01 Oct 2018 | ||
(Pariet 20 mg) | (psuqevendd) = eireuzpyxo babuaxbisw (pjswpkvqpd, qaswebkhnh - ekqrfgesps) View more | ||||||
Phase 2 | 80 | (Group A) | pnkphnxftb(vkntfddemh) = uwlxkvjqlk yyrcqixezk (ayjikcperb, tizvtpfihf - odftrfosth) View more | - | 12 Dec 2023 | ||
(Group B) | pnkphnxftb(vkntfddemh) = wmtnnmujsq yyrcqixezk (ayjikcperb, hswbnismtd - umuxfplxsq) View more | ||||||
Phase 2/3 | 337 | (E3810 20 mg Once Daily) | mqlnyxwzhm(issljylogd) = qgipqgeztm oegyqbiuzx (vvpmvykadb, pggxtegbwv - jlnmgkhhjs) View more | - | 13 Apr 2012 | ||
(E3810 10 mg Twice Daily) | mqlnyxwzhm(issljylogd) = qbhjzqwrkx oegyqbiuzx (vvpmvykadb, rotnlfdcwl - qgobfechgm) View more |